title: A susceptibility locus for Parkinson's disease maps to chromosome 2p13.
abstract: Parkinson's disease (PD) is a common degenerative neurologic disorder, which is pathologically characterized by a selective degeneration of dopaminergic neurons of the substantia nigra pars compacta, and the presence of characteristic eosinophilic inclusions, known as Lewy-bodies in affected brain areas. The cause of PD is unknown but, in recent years, genetic factors have been implicated in the aetiology of the disease. Firstly, clinico-genetic, epidemiologic and twin studies revealed inheritable effects and questioned earlier studies which had denied such influences. Secondly, several family studies suggested autosomal-dominant inheritance of syndromes which, to variable degrees, resembled sporadic PD clinically and in some cases also neuropathologically. Recently, a disease locus has been mapped to chromosome 4q21-22 in a large Mediterranean pedigree, in which disease expression is clinically and pathologically within the spectrum of sporadic PD; being atypical only for a relatively young mean age at onset of 46 years and rapid course of 10 years from onset to death. In affected individuals of this family and of three unrelated Greek kindreds, a putative disease-causing mutation has been identified in the gene encoding alpha-synuclein. With the first variant being defined, genetic heterogeneity has become apparent, as in other families parkinsonism was not linked to the 4q-locus and was not associated with the alpha-synuclein mutation (unpublished data). We describe a different genetic locus that appears to be involved in the development of parkinsonism closely resembling sporadic PD including a similar mean age of onset (59 years in the families, 59.7 years in sporadic PD; ref. 12). This locus was detected in a group of families of European origin. In two of these families, there is genetic evidence for a common founder. The penetrance of the mutation appears to be low, most likely below 40%. This is compatible with a possible role of this locus not only in familial, but also in typical (sporadic) PD.
authors.affiliation: Neurologische Klinik, Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany. tgasser@brain.nefo.med.uni-muenchen.de
authors.forename: T
authors.initials: T
authors.lastname: Gasser
authors.forename: B
authors.initials: B
authors.lastname: Müller-Myhsok
authors.forename: Z K
authors.initials: ZK
authors.lastname: Wszolek
authors.forename: R
authors.initials: R
authors.lastname: Oehlmann
authors.forename: D B
authors.initials: DB
authors.lastname: Calne
authors.forename: V
authors.initials: V
authors.lastname: Bonifati
authors.forename: B
authors.initials: B
authors.lastname: Bereznai
authors.forename: E
authors.initials: E
authors.lastname: Fabrizio
authors.forename: P
authors.initials: P
authors.lastname: Vieregge
authors.forename: R D
authors.initials: RD
authors.lastname: Horstmann
mesh_terms: D000328:Adult; D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D002889:Chromosomes, Human, Pair 2; D004198:Disease Susceptibility; D005260:Female; D005799:Genes, Dominant; D008040:Genetic Linkage; D005819:Genetic Markers; D006239:Haplotypes; D006801:Humans; D008126:Lod Score; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000235:genetics*; D010375:Pedigree
chemical_list: D005819:Genetic Markers